United States Antimony Outlook: A Cautious Technical Picture Amid Mixed Market Signals

Market Snapshot

Takeaway: United States Antimony (UAMY.A) faces a weak technical outlook, but fundamental and analyst optimism suggests a nuanced view for investors.

News Highlights

• Steel Tariff Hike: President Donald Trump announced a surprise plan to double U.S. tariffs on steel and aluminum from 25% to 50%. This move, expected to start soon, is likely to benefit U.S. steel producers but could harm global trading partners. As an antimony firm, UAMY.A is indirectly exposed to industry-wide demand shifts.
• Private Placements in Metals Sector: Several metals firms, including Galway Metals, Integral Metals, and CopAur Minerals, have recently announced the successful closing of private placements. These moves are positive for industry confidence and liquidity, which may support broader market sentiment for UAMY.A.

Analyst Views & Fundamentals

Analysts are currently in strong agreement on the stock. The simple average rating is 5.00, and the weighted rating also stands at 5.00, reflecting a "Strong Buy" recommendation from the only active analyst, Heiko F. Ihle. The analyst's historical win rate is 66.7%, and the average return on past recommendations is 27.48%, indicating a reliable track record.

The current price trend has risen by 30.02%, which aligns with the weighted expectations from analysts. The market is optimistic, though the high concentration of ratings from a single source may suggest a lack of diversity in perspectives.

Key Fundamentals

• Revenue-MV Score: 3.00 (internal diagnostic score), with value: 0.100 (10.00% of revenue-to-market value).
• Days Sales Outstanding: 1.00 (internal diagnostic score), with value: 15.43 days.
• Profit-MV Score: 2.00 (internal diagnostic score), with value: 0.0587 (5.87% of profit-to-market value).
• Net Income-Revenue: 2.00 (internal diagnostic score), with value: -13.32%.
• Cash-UP Score: 2.00 (internal diagnostic score), with value: 0.0322 (3.22% of cash-to-usage).
• ROE (Diluted): 1.00 (internal diagnostic score), with value: -5.66%.
• Asset-MV Score: 0.00 (internal diagnostic score), with value: -51.88% (51.88% of asset-to-market value).
• Cash-MV Score: 2.00 (internal diagnostic score), with value: 5.30% of cash-to-market value.

While fundamentals show a modest positive tilt, the weak ROE and net income figures raise concerns. Investors should watch for improvement in profitability indicators before committing.

Money-Flow Trends

Big money is showing a mixed but slightly bearish pattern. The overall inflow ratio is 49.12%, suggesting a modest outflow. Large and extra-large investors are more bearish, with inflow ratios of 50.04% and 48.87%, respectively. Retail investors (small and medium) also show a negative trend with inflow ratios of 48.98% and 49.98%. This indicates broader caution from both institutional and retail money.

Key Technical Signals

The technical outlook for UAMY.A is weak, with a technical score of 3.41 (internal diagnostic score). The bearish signals, such as Dark Cloud Cover and Long Lower Shadow, are stronger than any bullish ones.

• Long Lower Shadow: Internal diagnostic score of 2.32, indicating neutral bias.
• Long Upper Shadow: Internal diagnostic score of 6.90, showing a bullish bias.
• Dark Cloud Cover: Internal diagnostic score of 1.00, suggesting a strong bearish bias.

Over the last five days, the stock has shown Long Upper Shadow and Long Lower Shadow patterns multiple times, indicating a volatile and indecisive price action. The Dark Cloud Cover pattern on January 6, 2026, was a clear bearish signal.

The technical trend is characterized as weak, with 2 bearish indicators and 0 bullish indicators, making it a stock to avoid unless a strong reversal pattern forms.

Conclusion

While UAMY.A is currently favored by analysts and fundamentals suggest some upside potential, the weak technical indicators and recent bearish patterns suggest caution. Investors should wait for a clearer trend or a positive reversal in the charts before taking a position. A strong earnings report or better-than-expected guidance could also tip the scales in the stock's favor, but for now, the internal diagnostic score of 3.41 signals a need for patience and further observation.